N/A
Completed N=24
Virtual Path Planning for Image-guided Needle Interventions
gastrointestinal · Bone Diseases · Muscular Diseases · Spinal Diseases
Source: ClinicalTrials.gov NCT02021071 ↗
Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Aug 2016
Primary outcomePrimary: System Usability Scale (SUS) Score as a Measure of Qualitative Clinical Usefulness — 76 Scores on a scale
Summary
Philips Healthcare has added a virtual path planner to the current commercially available XperGuide software platform and that has the potential to significantly reduce dose during image-guided needle interventions.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY System Usability Scale (SUS) Score as a Measure of Qualitative Clinical Usefulness |
76 | — |
| SECONDARY Fluoroscopy Time |
1.31; 0.45 | — |
Eligibility Criteria
Inclusion Criteria
- Patients at any age who are referred for a clinically indicated XperGuide interventional procedure.
- The informed consent has been signed by the participant, parent or legal guardian as appropriate.
Exclusion Criteria
-Pregnant patients.
Data sourced from ClinicalTrials.gov (NCT02021071). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.